Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
592 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04650204 | Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy | terminated | Phase 4 | 4 | Mayo ClinicOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT02869789 | An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers | completed | Phase 4 | 1,041 | Bristol-Myers SquibbINDUSTRY | 21 | Jun 15, 2023 | clinicaltrials |
| NCT03859869 | A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI) | terminated | Phase 4 | 1 | AbbVieINDUSTRY | 1 | Jun 5, 2023 | clinicaltrials |
| NCT03043430 | Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients | terminated | Phase 4 | 10 | Brooke Army Medical CenterFED | 1 | Apr 25, 2023 | clinicaltrials |
| NCT00819832 | Anderson Circulating Tumor Cell Burden (CTCB) Study | terminated | Phase 4 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT00203996 | Polycystic Ovary Syndrome (PCOS) and Sleep Apnea | terminated | Phase 4 | 37 | University of ChicagoOTHER | 1 | Mar 21, 2023 | clinicaltrials |
| NCT04003012 | Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures | completed | Phase 4 | 10 | CAMC Health SystemOTHER | 1 | Mar 9, 2023 | clinicaltrials |
| NCT05185505 | Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria | recruiting | Phase 4 | 24 | The Methodist Hospital Research InstituteOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT03318393 | Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO | completed | Phase 4 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT03796195 | (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes | terminated | Phase 4 | 1 | Northwestern UniversityOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT03523000 | Determining the Prognostic Value of Continuous Intrathecal Infusion | completed | Phase 4 | 36 | University Hospitals Cleveland Medical CenterOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT01035099 | RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF | completed | Phase 4 | 41 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT03801031 | Sexual Dysfunction in Gynecologic Oncology Patients | terminated | Phase 4 | 4 | David BenderOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT04155008 | Nutrition and Pharmacological Algorithm for Oncology Patients Study | terminated | Phase 4 | 1 | Montefiore Medical CenterOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT02982954 | A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer(CHECKMATE 920) | completed | Phase 4 | 211 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 1, 2022 | clinicaltrials |
| NCT02596035 | An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma(CheckMate 374) | completed | Phase 4 | 197 | Bristol-Myers SquibbINDUSTRY | 1 | Oct 27, 2022 | clinicaltrials |
| NCT04320316 | A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)(ENS) | completed | Phase 4 | 1 | University of Alabama at BirminghamOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT04352439 | Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy | completed | Phase 4 | 19 | Duke UniversityOTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT03333655 | Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy | completed | Phase 4 | 15 | Hoffmann-La RocheINDUSTRY | 5 | Aug 12, 2022 | clinicaltrials |
| NCT03065218 | 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients | terminated | Phase 4 | 4 | Medstar Health Research InstituteOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT03988205 | Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia | terminated | Phase 4 | 3 | Medical College of WisconsinOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT01459666 | Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer | terminated | Phase 4 | 9 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT05359419 | Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities | unknown | Phase 4 | 20 | Goldman, Butterwick, Fitzpatrick and GroffOTHER | 1 | May 4, 2022 | clinicaltrials |
| NCT01999569 | The Role of Estrogen in Luteinizing Hormone Surge and Ovulation | completed | Phase 4 | 10 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT04571567 | A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis | completed | Phase 4 | 20 | Saakshi KhattriOTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT03727750 | Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML | completed | Phase 4 | 51 | PfizerINDUSTRY | 6 | Mar 25, 2022 | clinicaltrials |
| NCT02866695 | Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients | completed | Phase 4 | 20 | University of California, San FranciscoOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT03077204 | BIO4 Clinical Case Study: Cervical Spine | completed | Phase 4 | 20 | Seton Healthcare FamilyOTHER | 1 | Jan 14, 2022 | clinicaltrials |
| NCT01733147 | Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids | completed | Phase 4 | 60 | Mayo ClinicOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT02334722 | 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients | completed | Phase 4 | 81 | University of FloridaOTHER | 1 | Dec 15, 2021 | clinicaltrials |
| NCT03317795 | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids | completed | Phase 4 | 18 | Shannon K. Laughlin-TommasoOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT02436408 | VISmodegib for ORbital and Periocular Basal Cell Carcinoma(VISORB) | completed | Phase 4 | 35 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT02351700 | Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors | completed | Phase 4 | 62 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT05082441 | Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection | unknown | Phase 4 | 140 | Samaritan Health ServicesOTHER | 1 | Oct 19, 2021 | clinicaltrials |
| NCT03451071 | Postpartum HPV Vaccination | completed | Phase 4 | 195 | University of Alabama at BirminghamOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT01861717 | A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. | terminated | Phase 4 | 4 | Saint John's Cancer InstituteOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT00153868 | A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer | completed | Phase 4 | 43 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT00837434 | Anti-TNF Agents for the Treatment of Rheumatoid Arthritis | completed | Phase 4 | 63 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 22, 2021 | clinicaltrials |
| NCT03252223 | Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS | completed | Phase 4 | 33 | University of California, San DiegoOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT02911961 | APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors | withdrawn | Phase 4 | 0 | Denver Health and Hospital AuthorityOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT04031885 | A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer | terminated | Phase 4 | 4 | Eli Lilly and CompanyINDUSTRY | 2 | Aug 24, 2021 | clinicaltrials |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | completed | Phase 4 | 4,372 | PfizerINDUSTRY | 30 | Aug 17, 2021 | clinicaltrials |
| NCT02476994 | Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion | terminated | Phase 4 | 1 | Baxter Healthcare CorporationINDUSTRY | 1 | Jul 21, 2021 | clinicaltrials |
| NCT03870685 | Surgical Site Infiltration of Exparel vs TAP Block With Exparel in Patients Undergoing Laparotomy Via Midline Incision | unknown | Phase 4 | 43 | Danbury HospitalOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT03040024 | Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients | terminated | Phase 4 | 71 | Emory UniversityOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT00980018 | An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment(MACS0999) | completed | Phase 4 | 52 | Novartis PharmaceuticalsINDUSTRY | 2 | Jul 1, 2021 | clinicaltrials |
| NCT01812759 | Fentanyl for Breakthrough Pain in the Emergency Department | terminated | Phase 4 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT04937244 | Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of Gliomas | unknown | Phase 4 | 10 | Northwell HealthOTHER | 1 | Jun 23, 2021 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials